News

Ashland shares rose after a report that activist investor Ancora has taken a stake in the specialty chemicals company. Ancora's involvement typically signals potential pressure for strategic or operational changes. No further details on the size of the stake or Ancora's specific demands have been disclosed.

Strategy (formerly MicroStrategy) disclosed a new bitcoin purchase, but the announcement failed to generate a notable upward move in BTC price. The market reaction suggests the market has largely priced in Strategy's recurring bitcoin acquisitions. No specific purchase size or price details were provided in the article.

A Chinese mining CEO commented that Strategy (formerly MicroStrategy) could withstand a bitcoin price drop to $30,000 without being forced to sell its holdings. The statement implies confidence in Strategy's balance sheet resilience at significantly lower BTC price levels. No new corporate action or financial disclosure was announced.

OpenAI has confidentially filed for a US IPO targeting a valuation of up to $1 trillion, with a potential September debut; no size or firm terms were disclosed. The Pentagon added Alibaba, Baidu, and BYD to its 1260H China military-linked firms list, barring direct Defense Department contracts. AstraZeneca reported its obesity pill cut body weight by 10.5% in a Phase II trial, while broader Asia-Pacific macro items included China's May trade beat and a PBOC yuan fixing at its strongest since February 2023.

OpenAI has confidentially filed for an initial public offering in the United States, according to the company. No timeline for the public launch of the IPO has been determined yet.